NCT03673397

Brief Summary

The aim of this trial is to investigate the effects of a single bout of aerobic exercise on sleep in patients with depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable depression

Timeline
Completed

Started Sep 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 17, 2018

Completed
7 days until next milestone

Study Start

First participant enrolled

September 24, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2020

Completed
Last Updated

February 7, 2020

Status Verified

February 1, 2020

Enrollment Period

1.3 years

First QC Date

June 28, 2018

Last Update Submit

February 6, 2020

Conditions

Keywords

ExerciseSleepDepressionHeart rate variabilityBlood pressurerandomized controlled trialpolysomnography

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in sleep efficiency (%) at follow-up assessed by polysomnography

    Calculated as (total sleep time / total recording time) \* 100. Higher values represent a better outcome. A one-way ANCOVA will be computed with baseline sleep efficiency (%) and minimization factors as covariates, intervention as the independent variable, and follow-up sleep efficiency (%) as the dependent variable.

    Baseline (night 1) and follow-up (night 2)

Secondary Outcomes (19)

  • Change from baseline in wake after sleep onset (minutes) at follow-up assessed by polysomnography

    Baseline (night 1) and follow-up (night 2)

  • Change from baseline in sleep onset latency (minutes) at follow-up assessed by polysomnography

    Baseline (night 1) and follow-up (night 2)

  • Change from baseline in number of awakenings at follow-up assessed by polysomnography

    Baseline (night 1) and follow-up (night 2)

  • Change from baseline in stage 1 sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography

    Baseline (night 1) and follow-up (night 2)

  • Change from baseline in stage 2 sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography

    Baseline (night 1) and follow-up (night 2)

  • +14 more secondary outcomes

Other Outcomes (1)

  • Mood assessed by self-rating questionnaire 'Befindlichkeitsskala' (BFS)

    Immediately before and at the end of the control condition as well as the exercise intervention.

Study Arms (2)

Aerobic exercise

EXPERIMENTAL

Patients allocated to the intervention group will perform a single bout of supervised aerobic exercise. The starting time will be approximately 1630 hrs. The exercise mode will be a bicycle ergometer. After a warm-up period, during which the intensity is gradually increased, an intensity of 80% of the individual anaerobic threshold will be maintained for 30 minutes. The intensity level was chosen based on clinical experience that this corresponds to an approximate rate of perceived exertion of 13 (on a scale from 6-20) in this population.

Behavioral: Aerobic exercise, bicycle ergometer

Control

NO INTERVENTION

Individuals allocated to the control group will be placed in a room with analogous conditions to the exercise group concerning light, temperature and absence of music at the same time as individuals performing the exercise intervention. The control group will be asked to remain seated and read magazines.

Interventions

Exercise performed below individual anaerobic threshold for 30 minutes

Aerobic exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inpatient psychosomatic rehabilitation in the clinic OBERWAID, St.Gallen, Switzerland
  • Age: ≥18 and ≤65 years old
  • Primary diagnosis of depression (F32, F33) without psychotic episode according to International Statistical Classification of Diseases, 10th edition

You may not qualify if:

  • Regular use of hypnotic agents (patients were included if no hypnotic agents were taken 2 weeks prior to study participation)
  • Factors precluding exercise testing or training
  • Use of beta-blockers (with the exception of Carvedilol \& Nebivolol)
  • Use of opioids
  • History of epilepsy
  • Restless legs syndrome defined by ≥7 points on the restless legs syndrome screening questionnaire (RLSSQ)
  • Moderate or severe sleep apnea defined by an oxygen desaturation index (ODI) ≥15 in the first polysomnography.
  • Morbid adiposity with BMI \>40

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oberwaid Ag

Sankt Gallen, 9016, Switzerland

Location

Related Publications (2)

  • Brupbacher G, Zander-Schellenberg T, Straus D, Porschke H, Infanger D, Gerber M, von Kanel R, Schmidt-Trucksass A. The acute effects of aerobic exercise on sleep in patients with unipolar depression: a randomized controlled trial. Sleep. 2021 Nov 12;44(11):zsab177. doi: 10.1093/sleep/zsab177.

  • Brupbacher G, Straus D, Porschke H, Zander-Schellenberg T, Gerber M, von Kanel R, Schmidt-Trucksass A. The acute effects of aerobic exercise on sleep in patients with depression: study protocol for a randomized controlled trial. Trials. 2019 Jun 13;20(1):352. doi: 10.1186/s13063-019-3415-3.

MeSH Terms

Conditions

DepressionSleep Wake DisordersParasomniasSleep DeprivationSleep Initiation and Maintenance DisordersMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersDyssomniasSleep Disorders, Intrinsic

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Gavin Brupbacher, MSc

    Oberwaid AG

    PRINCIPAL INVESTIGATOR
  • Hildburg Hildburg, MD

    Oberwaid AG

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2018

First Posted

September 17, 2018

Study Start

September 24, 2018

Primary Completion

January 6, 2020

Study Completion

January 6, 2020

Last Updated

February 7, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will share

De-identified (i.e. coded) individual participant data that underlie the results of published articles, including data dictionaries, will be available upon request under the creative commons license CC-BY. Requests will only be granted for use in individual participant data meta-analysis which has been approved by an independent review committee. Exceptions to these rules are reserved within the context of peer-reviewed publications, provided that data integrity remains intact. Data will be provided upon request immediately after publication of peer-reviewed articles with no end date. Requests should be sent to the e-mail address detailed in the Dataverse repository https://doi.org/10.7910/DVN/WASN36.

Shared Documents
STUDY PROTOCOL
More information

Available IPD Datasets

Individual Participant Data Set Access

Locations